Featured Research

from universities, journals, and other organizations

New Study Strengthens Association Of Prostate Cancer With Exposure To Agent Orange

Date:
May 16, 2008
Source:
American Urological Association
Summary:
As men age, their risk of developing prostate cancer increases. Aging Vietnam veterans are giving researchers new opportunities to solidify the connection between in-country exposure to Agent Orange and subsequent prostate cancer development.

As men age, their risk of developing prostate cancer increases. Aging Vietnam veterans are giving researchers new opportunities to solidify the connection between in-country exposure to Agent Orange and subsequent prostate cancer development. In a study presented during the Annual Scientific Meeting of the American Urological Association (AUA) in Orlando, researchers presented data from a large study of veterans enrolled in the Northern California VA System, examining prostate cancer incidence and disease characteristics in those exposed to Agent Orange compared to those who were not exposed.

Related Articles


More than 13,000 Vietnam Veterans were divided into two groups based on their exposure to Agent Orange. Twice as many men exposed to Agent Orange were identified with prostate cancer. Agent Orange-exposed men were also diagnosed younger and were more likely to present with aggressive or metastatic disease.  Other prostate cancer risk factors – race, body-mass index (BMI) and smoking – were not statistically different between the two groups.

This increased evidence suggests that exposure to Agent Orange should be considered a risk factor for developing prostate cancer, similar to African-American heritage or a family history of the disease.

About Agent Orange

Agent Orange is a combination of two synthetic compounds known to be contaminated with the dioxin tetrachlorodibenzo-para-dioxin (TCDD) during the manufacturing process. Named for the color of the barrel in which it was stored, Agent Orange was one of many broad-leaf defoliants used in Vietnam to destroy enemy ground cover. It is estimated that more than 20 million gallons of the chemicals, also known as “rainbow herbicides,” were used between 1962 and 1971; approximately half of the herbicides were Agent Orange.  In 1997, the International Agency for Research on Cancer re-classified TCDD as a Group 1 carcinogen, a classification that includes arsenic, asbestos and gamma radiation.


Story Source:

The above story is based on materials provided by American Urological Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Chamie K, deVere White RW, Ellison LM: Agent Orange exposure, Vietnam War veterans and the risk of prostate cancer. J Urol, suppl., 2008; 179: 149, abstract 421. [link]

Cite This Page:

American Urological Association. "New Study Strengthens Association Of Prostate Cancer With Exposure To Agent Orange." ScienceDaily. ScienceDaily, 16 May 2008. <www.sciencedaily.com/releases/2008/05/080515072810.htm>.
American Urological Association. (2008, May 16). New Study Strengthens Association Of Prostate Cancer With Exposure To Agent Orange. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2008/05/080515072810.htm
American Urological Association. "New Study Strengthens Association Of Prostate Cancer With Exposure To Agent Orange." ScienceDaily. www.sciencedaily.com/releases/2008/05/080515072810.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins